REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 8th, 2016 • Balance Labs, Inc. • Services-management consulting services • New York
This Registration Rights Agreement (the “Agreement”), dated as of April 1, 2016 (the “Execution Date”), is entered into by and between Balance Labs, Inc., a Delaware corporation (the “Company”), with its principal executive office at 1111 Lincoln Road, 4th Floor, Miami Beach, Florida 33139, and NEWEL TRADING GROUP, LLC, a [Delaware] limited partnership (the “Investor”), with its principal executive office at 152 West 57th Street, 4th Floor, New York, NY 10019.
INVESTMENT AGREEMENTInvestment Agreement • April 8th, 2016 • Balance Labs, Inc. • Services-management consulting services • New York
This INVESTMENT AGREEMENT (the “Agreement”), dated as of April 1, 2016 (the “Execution Date”), is entered into by and between Balance Labs, Inc., a Delaware corporation (the “Company”), with its principal executive office at 1111 Lincoln Road, 4th Floor, Miami, Florida 33139, and NEWEL TRADING GROUP, LLC, a Delaware limited partnership (the “Investor”), with its principal executive office at 152 West 57th Street, 4th Floor, New York, NY 10019.
BALANCE LABS, INC. Convertible DebentureConvertible Security Agreement • April 8th, 2016 • Balance Labs, Inc. • Services-management consulting services • New York
This Convertible Debenture (the “Debenture”) is duly authorized and issued by Balance Labs, Inc., a Delaware corporation, (the “Company”), having its principal executive office at 1111 Lincoln Road, 4th Floor, Miami Beach, Florida.
COMMON STOCK PURCHASE WARRANT Balance Labs, inc.Securities Agreement • April 8th, 2016 • Balance Labs, Inc. • Services-management consulting services
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, NEWEL TRADING GROUP, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or prior to the close of business on April 1, 2019 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Balance Labs, Inc., a Delaware corporation (the “Company”), up to 2,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
